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In response to enteric pathogens, the inflamed intes-
tine produces antimicrobial proteins, a process
mediated by the cytokines IL-17 and IL-22. Salmo-
nella enterica serotype Typhimurium thrives in the in-
flamed intestinal environment, suggesting that the
pathogen is resistant to antimicrobials it encounters
in the intestinal lumen. However, the identity of these
antimicrobials and corresponding bacterial resis-
tance mechanisms remain unknown. Here, we report
that enteric infection of rhesus macaques and mice
with S. Typhimurium resulted in marked Il-17- and
IL-22-dependent intestinal epithelial induction and
luminal accumulation of lipocalin-2, an antimicrobial
protein that prevents bacterial iron acquisition.
Resistance to lipocalin-2, mediated by the iroBCDE
iroN locus, conferred a competitive advantage to
the bacterium in colonizing the inflamed intestine of
wild-type but not of lipocalin-2-deficient mice.
Thus, resistance to lipocalin-2 defines a specific
adaptation of S. Typhimurium for growth in the in-
flamed intestine.
INTRODUCTION
Salmonella enterica serotype Typhimurium (S. Typhimurium)
causes a localized gastroenteritis in humans, characterized by
acute intestinal inflammation and diarrhea. The pathogen
encodes two type III secretion systems (T3SS-1 and T3SS-2)
that are important for eliciting intestinal inflammation (Hapfelme-
ier et al., 2005; Tsolis et al., 1999). The initiation of inflammatory
responses in tissue requires direct contact between bacteria and
host cells, including epithelial cells, macrophages, and dendritic
cells. Macrophages and dendritic cells infected with S. Typhimu-
rium are a source of cytokines, including interleukin (IL)-23476 Cell Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier Inand IL-18, which help to amplify responses in tissue (Godinez
et al., 2009; Srinivasan et al., 2007). For example, IL-23 stimu-
lates T cells in the intestinal mucosa to produce IL-17 and
IL-22 (Godinez et al., 2009), two cytokines whose expression is
among the ones most prominently induced during S. Typhimu-
rium infection (Godinez et al., 2008; Raffatellu et al., 2008). The
cytokine storm ensuing from the amplification of inflammatory
responses in tissue results in the activation of antimicrobial
responses in the intestinal mucosa.
One important component of the antimicrobial response
induced by the IL-23/IL-17 axis is the recruitment of neutrophils
(Godinez et al., 2008, 2009; Raffatellu et al., 2008). The extrava-
sation of neutrophils into the mucosa provides a formidable anti-
bacterial defense to prevent S. Typhimurium dissemination.
Support for this notion comes from clinical data, showing that
neutropenia is a risk factor for bacteremia with nontyphoidal
Salmonella serotypes (Noriega et al., 1994). Thus, S. Typhimu-
rium appears to be susceptible to this arm of the host defense.
A second component of the antimicrobial response is the
production in the intestinal mucosa of antimicrobial proteins
(Godinez et al., 2009; Raffatellu et al., 2008; Zheng et al.,
2008), whose release into the intestinal lumen may be respon-
sible for the dramatic changes in the microbiota observed during
inflammation (Lupp et al., 2007; Stecher et al., 2007). The cyto-
kines IL-17 and IL-22 are required for the production in the in-
flamed intestine of antimicrobials (Godinez et al., 2009; Raffatellu
et al., 2008), including lipocalin-2, a protein that inhibits bacterial
growth by interfering with the acquisition of an essential nutrient,
iron (Berger et al., 2006; Flo et al., 2004; Goetz et al., 2002).
However, the cells targeted by IL-17 and IL-22 in vivo to induce
production of these antimicrobials have not been identified.
S. Typhimurium appears to be resistant against this arm of the
host defense, because its numbers in the intestinal lumen
increase dramatically during inflammation, resulting in increased
fecal oral transmission (Barman et al., 2008; Lawley et al., 2008;
Stecher et al., 2007). We thus hypothesized that, in addition
to virulence mechanisms to induce intestinal inflammation,
S. Typhimurium should possess virulence mechanisms toc.
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lumen. While the virulence factors involved in triggering intestinal
inflammation, suchasT3SS-1andT3SS-2, arewell characterized,
the identity of theantimicrobial responsespotentially encountered
in the lumen of the inflamed intestine and the identity of the corre-
sponding bacterial resistance genes are currently unknown.
To gain further insights into this ‘‘inflammation-adapted’’ path-
ogenic lifestyle of S. Typhimurium, we set out to identify antimi-
crobials released by intestinal epithelial cells into the intestinal
lumen during inflammation. After identifying one such antimicro-
bial, we determined whether the corresponding S. Typhimurium
resistance genes conferred an advantage during bacterial
growth in the inflamed intestine.
RESULTS
Gene Expression Profile Induced by IL-17 and IL-22
in Human Intestinal Model Epithelia
To identify antimicrobial responses elicited by IL-17 and IL-22 in
the intestinal epithelium, human colonic cancer epithelial (T84)
cells were polarized and basolaterally stimulated with IL-17 or
IL-22. Expression of CCL20, a chemokine gene known to be
induced by IL-17 in lung epithelial cells (Kao et al., 2005), was
found to be induced optimally 4 hr after stimulation with IL-17
or IL-22 (data not shown). To determine the complete molecular
profile of epithelial responses, RNA from four replicates was iso-
lated 4 hr after stimulation of T84 cells with IL-22 or IL-17, and
global gene expression profiles were elucidated by microarray
analysis.
In general, IL-22 produced more robust responses in T84 cells
than IL-17 (Figure S1). For example, the number of genes upre-
gulated 2-fold or more was 849 for IL-22 treatment compared to
only 62 for IL-17 treatment. A table containing a complete listing
of genes with significantly (p < 0.05) altered expression in T84
epithelial cells after stimulation with IL-17 or IL-22 can be
accessedat theGeneExpressionOmnibusdatabase (GSE11345).
Meta Analysis of In Vitro and In Vivo Gene Expression
Profiles Suggests a Contribution of Epithelial Cells
to Host Defense Responses during Inflammation
To identify those antimicrobial responses induced in vitro in T84
cells that are also observed in the inflamed intestine in vivo, we
performedmeta analysis of the overlap in upregulated gene tran-
scription (>2-fold) between T84 cells stimulated with IL-22 and
the ileal mucosa of rhesus macaques infected with S. Typhimu-
rium (Figure 1). The in vivo gene expression profile analyzed in
this study had previously been generated using an adult healthy
rhesus macaque that had undergone ligated ileal loop surgery
(Raffatellu et al., 2008). Two ligated ileal loops had been inocu-
lated with either sterile culture medium (mock infection) or with
S. Typhimurium, and 5 hr later, both loops had been surgically
removed to isolate RNA for gene expression profiling (Raffatellu
et al., 2008). Meta analysis revealed a substantial overlap
between transcripts whose levels were increased in the ileal
mucosa of a rhesus macaque during S. Typhimurium infection
and those whose expression was induced in human T84 epithe-
lial cells upon stimulation with IL-22 (302 transcripts) (Figure 1A).
A functional category that was statistically overrepresented
included genes involved in defense responses, encoding antimi-Celcrobials (LCN2, NOS2, and MUC4) and cytokines (CCL20)
whose expression was increased most dramatically both
in vitro in IL-22-treated T84 cells and during S. Typhimurium
infection in vivo (Figure 1A). These data supported the hypoth-
esis that IL-22 induced expression of antimicrobials in epithelial
cells during S. Typhimurium infection in the intestinal mucosa.
IL-17 and IL-22 Synergize to Induce Lipocalin-2
Production in Intestinal Epithelial Cells
Transcripts encoding the antimicrobial lipocalin-2 were among
the ones most prominently increased both in vitro after IL-22
stimulation and in vivo after S. Typhimurium infection
(Figure 1A). Thus, after validating results from gene expression
profiling for selected genes by real-time PCR (Figure S2), we
sought to further investigate whether intestinal epithelial cells
may be a source of lipocalin-2 during S. Typhimurium infection.
First, we verified that lipocalin-2 is an antimicrobial produced by
intestinal epithelial cells. Quantification of changes in gene
expression by real-time PCR confirmed that stimulation of T84
cells with IL-22 resulted in an induction of LCN2 expression
(7.9-fold) (Figure 1B). Stimulation with IL-17 alone did not alter
LCN2 transcription (1.3-fold change), but further increased
LCN2 transcription when added in combination with IL-22
(17-fold). We next determined protein secretion by ELISA. Non-
stimulated T84 cells secreted a small amount of lipocalin-2
apically (approximately 2 ng/ml), while the amount detected in
the basolateral compartment was negligible. Stimulation of T84
cells with IL-22 but not with IL-17 resulted in apical and basolat-
eral secretion of lipocalin-2 at levels above those detected with
nonstimulated controls. Stimulation with both IL-17 and IL-22 re-
sulted in a significant (p < 0.05) further increase of lipocalin-2
secretion both apically and basolaterally, reaching substantial
concentrations (approximately 20 ng/ml) in both compartments
(Figure 1C). In contrast, CCL20 was secreted exclusively into
the basolateral compartment after cytokine stimulation of T84
cells (Figure S2). Although IL-17 by itself did not markedly alter
LCN2 transcription, our data suggested that this cytokine syner-
gized with IL-22 in controlling production of lipocalin-2 in the
intestinal epithelium.
Because lipocalin-2 was highly induced during S. Typhimu-
rium infection in vivo, we next investigated whether expression
of LCN2 was induced by cytokines (i.e., IL-17 and IL-22) present
in the inflamed intestine, by direct contact of bacteria with
epithelial cells, or by a combination of both mechanisms. Baso-
lateral stimulation of T84 cells with purified flagellin or infection of
T84 cells with the S. Typhimurium wild-type strain, an invasion-
deficient strain (invA mutant), or a nonflagellated strain (fliC fljB
mutant) did not result in marked induction in LCN2 expression
(Figure 1D). Treatment of T84 cells with IFNg did not increase
LCN2 transcription. The marked increase in LCN2 transcription
observed after basolateral stimulation of T84 cells with IL-17
and IL-22 was modestly increased by basolateral stimulation
with purified flagellin (p = 0.03) or by S. Typhimurium infection
(p = 0.004). These data suggested that induction of LCN2 tran-
scription was mediated largely through stimulation with IL-17
and IL-22. Although direct interaction between bacteria and
host cells was not sufficient to induce LCN2 transcription, these
interactions could further increase LCN2 mRNA levels induced
by treatment with IL-17 and IL-22.l Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier Inc. 477
Cell Host & Microbe
Salmonella Resistance to InflammationFigure 1. Expression of Lipocalin-2 by Polarized Intestinal Model Epithelia upon Stimulation with IL-17 and/or IL-22
(A) Meta analysis of the overlap (gray circles) between increases (>2-fold) in transcripts in the ileal mucosa of rhesus macaques during S. Typhimurium infection
(x axis) and induction of gene expression observed in human T84 epithelial cells after treatment with IL-22 (y axis). The identity of selected genes (closed circles) is
indicated.
(B) Detection of LCN2 expression in polarized T84 cells stimulated for 4 hr with reagents listed below graph using quantitative real-time PCR.
(C) Secretion of lipocalin-2 by T84 cells into the apical (open bars) or basolateral (closed bars) compartment detected by ELISA.
(D) Detection of LCN2 expression in polarized T84 cells stimulated for 4 hr with reagents listed below graph using quantitative real-time PCR. For (B)–(D), data
represent means ± SD from at least three different experiments.Lipocalin-2 Produced by Epithelial Cells
after Stimulation with IL-17 and IL-22 Inhibits
Bacterial Growth
To investigate the biological significanceof the IL-17/IL-22-medi-
ated lipocalin-2 production by intestinal epithelial cells, we deter-
mined whether the protein was produced at levels that exhibited
anantimicrobial activity. Lipocalin-2specifically bindsenteroche-
lin, a smallmolecular weight iron chelator (siderophore) produced
bymanymembers of the Enterobacteriaceae. As a result, lipoca-
lin-2 exhibits a bacteriostatic effect on bacteria that depend
exclusively on enterochelin to acquire iron, an essential trace478 Cell Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier Ielement, during growth in the host (Berger et al., 2006; Flo
et al., 2004; Goetz et al., 2002). The iroBCDE iroN gene cluster
of S. Typhimurium encodes proteins involved in the biosynthesis
and uptake of salmochelin, a glycosylated derivative of entero-
chelin (Ba¨umler et al., 1996, 1998; Bister et al., 2004; Hantke
et al., 2003; Rabsch et al., 1999; Zhu et al., 2005). Salmochelin
is not bound by lipocalin-2, and its production therefore renders
S. Typhimurium lipocalin-2 resistant. However, in the absence
of a functional iroBCDE iroN gene cluster, S. Typhimurium
produces enterochelin as its sole siderophore and is lipocalin-2
sensitive (Crouch et al., 2008; Fischbach et al., 2006).nc.
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Salmonella Resistance to InflammationFigure 2. The iroBC Locus Confers Lipocalin-2 Resistance by Overcoming Iron Limitation
(A) Growth of the S. Typhimurium wild-type or an isogenic iroBC mutant in medium collected from polarized T84 cells that either had not been stimulated with
cytokines (control, open bars) or had been stimulated with IL-17 and IL-22 for 24 hr (IL-17 + IL-22, closed bars). Bacterial numbers were determined 5 hr after
inoculation with 103 bacteria.
(B) Bacterial growth in rich medium (LB broth).
(C) Bacterial growth in tissue culture medium (DMEM) supplemented with lipocalin-2 (LCN) or ferrioxamine B (FoxB) or containing no supplements. ND, not deter-
mined. All data represent means ± SD from at least three different experiments.Growth of the S. Typhimurium wild-type (lipocalin-2 resistant)
and a S. Typhimurium iroBC mutant (lipocalin-2 sensitive) were
compared in medium collected either from nonstimulated T84
cells (control) or from T84 cells after stimulation with IL-17 and
IL-22 (Figure 2). No differences between the S. Typhimurium
wild-type and the iroBCmutant were observed in control media;
however, growth of the iroBCmutant was significantly (p < 0.05)
reduced in media in which lipocalin-2 production had been eli-
cited by stimulation with IL-17 and IL-22 (Figure 2A). These
data suggested that the amount of lipocalin-2 produced by intes-
tinal epithelial cells upon IL-17/IL-22 stimulation was sufficient to
reduce growth of the iroBC mutant in vitro.
A mutation in iroBC did not impair bacterial growth in rich
media (Luria-Bertani broth) (Figure 2B). Tissue culture medium
was spiked with lipocalin-2 to confirm that the presence of this
antimicrobial was responsible for the growth defect observed
with the iroBC mutant. The presence of lipocalin-2 significantly
(p < 0.05) reduced growth of the iroBC mutant, while growth of
the S. Typhimurium wild-type was not affected (Figure 2C).
Complementation of the iroBC mutant with the cloned iroBCDE
iroN gene cluster restored resistance to lipocalin-2, as indicated
by equal growth in tissue culture medium in the presence or
absence of lipocalin-2 (Figure 2C). The lipocalin-2-mediatedCelgrowth inhibition of the iroBC mutant could be prevented when
iron was supplied in the form of ferrioxamine B (iron-desferal),
a siderophore that can be internalized by the FoxA outer
membrane receptor of S. Typhimurium (Figure 2C). Collectively,
these data suggested lipocalin-2 inhibited growth of the iroBC
mutant through iron sequestration.
S. Typhimurium Infection Induces LCN2 Expression
in Intestinal Epithelial Cells of Rhesus Macaques
and Secretion of Lipocalin-2 into the Intestinal Lumen
To investigate the in vivo relevance of lipocalin-2 production by
T84 cells, we examined the contribution of epithelial cells ex-
pressing this antimicrobial protein during S. Typhimurium infec-
tion in a relevant host. To this end, we first localized the LCN2
transcripts in the ileal mucosa of rhesus macaques using
in situ hybridization (Figure 3). LCN2 transcripts localized to
epithelial cells lining the villi and crypts, with intense staining in
tissue from S. Typhimurium-infected ileal loops with a LCN2-
specific cDNA probe (Figure 3A). These data suggested that
LCN2 was mainly expressed by intestinal epithelial cells during
S. Typhimurium infection.
Next, we determined the absolute number of LCN2 transcripts
using quantitative real-time PCR. For each rhesus macaquel Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier Inc. 479
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a S. Typhimurium-infected loop were processed for mRNA isola-
tion. Transcripts encoding b-actin (ACT1) were detected at
similar levels in both treatment groups, averaging approximately
20,000 copies/ng RNA in samples from mock-infected and
S. Typhimurium-infected loops (Figure 3B). Based on theoretical
assumptions about the RNA content of 106 cells (5–8 mg) (Ausu-
bel et al., 1994), these data would predict that ACT1was present
on average in 100–160 copies/cell. Our data were thus within the
range of previous measurements by real-time PCR, indicating
that human leukocytes contain between 84 and 491 copies of
ACT1 per cell (Lupberger et al., 2002). LCN2 transcripts aver-
aged 1400 copies/ng RNA in samples frommock-infected loops,
but the copy number was significantly (p = 0.03) increased after
S. Typhimurium infection, averaging 48,000 copies/ng RNA.
Collectively, these data suggested that during S. Typhimurium
Figure 3. Spatial andQuantitative Analysis of Lipo-
calin-2 Expression in the Ileal Mucosa of Rhesus
Macaques during S. Typhimurium Infection
(A) Detection of LCN2 transcripts (brown precipitate) in
representative sections from a S. Typhimurium-infected
loop (left panel) and a mock-infected loop (right panel)
from the same animal by in situ hybridization. Hybridiza-
tion with the empty plasmid vector used for cloning the
LCN2 probe was performed as a negative control (middle
panel). All sections were counterstained with hematoxylin.
(B) Absolute transcript levels of LCN2 and ACT1 in mock-
infected (closed bars) and S. Typhimurium-infected (open
bars) loops from four rhesus macaques. Data represent
mean mRNA copy numbers per ng of RNA ± SEM. Statis-
tically significant (p < 0.05) differences are indicated by
P values.
(C–E) Detection of lipocalin-2 (brown precipitate) in repre-
sentative sections from a S. Typhimurium-infected loop
(C and D) and a mock-infected loop (E) from the same
animal using immunohistochemistry with rabbit anti-
rhesus lipocalin-2 antiserum (a-lipocalin-2). Immunohisto-
chemistry with preimmune serum was performed as
a negative control (D).
(F) Lipocalin-2 secretion in mock-infected (closed bars)
and S. Typhimurium-infected (open bars) loops from four
rhesus macaques. Data represent the total amount of lip-
ocalin-2 (ng) secreted into an approximately 5 cm long
segment of the ileum. Statistically significant (p < 0.05)
differences are indicated by P values.
infection, the LCN2 gene was expressed at
a very high level in the epithelium of the ileal
mucosa.
We next studied the production of lipocalin-2
in situ using immunohistochemistry (Figures
3C–3E). Rabbit polyclonal antibody derived
from recombinant rhesus lipocalin-2 was gener-
ated. Immunostaining of formalin-fixed tissue
revealed that after S. Typhimurium infection, lip-
ocalin-2 was abundant in intestinal epithelial
cells and in the underlying lamina propria. These
data suggested that lipocalin-2 protein is
produced and secreted in tissue during the
course of an infection with S. Typhimurium.
Next, we wanted to detect the amount of lipoca-
lin-2 secreted into the intestinal lumen in vivo. An ELISA was
developed to detect the amount of lipocalin-2 secreted into the
luminal fluid previously collected from ligated ileal loops of
rhesus macaques 8 hr after inoculation with S. Typhimurium
(n = 4) or sterile culture medium (n = 4). Luminal contents of
S. Typhimurium-infected loops contained on average 419 ng of
lipocalin-2, which was significantly higher (p = 0.007) than the
64 ng lipocalin-2 detected in luminal contents of mock-infected
loops (Figure 3F). Collectively, these data identified lipocalin-2
production as an antimicrobial response encountered in the
lumen of the inflamed intestine.
Lipocalin-2 Resistance Confers an Advantage during
Growth of S. Typhimurium in the Inflamed Intestine
After identifying lipocalin-2 as an antimicrobial response
encountered in the intestinal lumen, we wanted to determine480 Cell Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier Inc.
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Salmonella Resistance to InflammationFigure 4. Growth of iroN-Deficient and iroN-
Proficient S. Typhimurium Strains in the
Murine Intestine In Vivo
(A) Recovery of S. Typhimurium from colon
contents 48 hr after infection of mice with the
S. Typhimurium wild-type or an iroN mutant.
Each circle represents bacterial numbers recov-
ered from an individual animal. Bars indicate the
geometric mean.
(B) Recovery of S. Typhimurium 48 hr after
competitive infection with the indicated bacterial
strains. Bars indicate the average competitive
index (i.e., ratio of wild-type/iroN or ratio of invA
spiB/invA spiB iroN) of bacteria recovered from
colon contents of wild-type mice or Lcn2/
mice 48 hr after infection with a 1:1 mixture of
the respective S. Typhimurium strains. Data repre-
sent geometric means ± SEM.whether the corresponding S. Typhimurium resistance genes
would confer an advantage during bacterial growth in the in-
flamed intestine. To establish cause and effect using lipocalin-
2-deficient animals, we used the streptomycin-pretreated
mouse model for these studies. S. Typhimurium infection of
streptomycin-pretreated mice results in acute inflammation of
the cecal mucosa (Barthel et al., 2003), which is accompanied
by overgrowth of S. Typhimurium in the lumen of the large intes-
tine (Que et al., 1986; Stecher et al., 2007).
We first investigatedwhether inactivation of iroN, encoding the
IroN outer membrane salmonchelin receptor protein, would
reduce the ability of S. Typhimurium to grow in the intestinal
lumen of streptomycin-pretreated wild-type mice (C57BL/6)
(Figure 4). The iroNmutant was sensitive to lipocalin-2-mediated
iron deprivation in vitro (Figure 2C). At 48 hr after infection of
streptomycin-pretreated mice, the iroN mutant was recovered
in reduced numbers from colon contents compared to the S. Ty-
phimurium wild-type strain (Figure 4A). However, there was
a large animal-to-animal variation in bacterial numbers recov-
ered fromcolon contents.We next investigatedwhether a lipoca-
lin-2-sensitive S. Typhimurium mutant (iroN mutant) was able to
compete with the S. Typhimurium wild-type in vivo. Using this
experimental design, the ability of the iroN mutant and the
wild-type to colonize the intestine is compared in each individual
animal, thereby reducing the effect of animal-to-animal variation.
Streptomycin-pretreated wild-type mice were inoculated intra-
gastrically with sterile LB broth (mock infection) or with a 1:1
mixture of the S. Typhimurium wild-type and the iroN mutant.
Compared to mock-infected mice, mice inoculated with the
S. Typhimurium strain mixture exhibited markedly increased
transcript levels of cytokine genes, including Il17, Il22, keratino-
cyte-derived cytokine (Kc, Cxcl1), and TNF-a (Tnfa) at 48 hr after
infection (Figures 5A–5D). Furthermore, S. Typhimurium infec-
tion caused marked inflammatory changes in the submucosa
and mucosa (Figure 6). These data confirmed that S. Typhimu-
rium infection of streptomycin-pretreated mice was associated
with acute cecal inflammation. Importantly, transcript levels of
Lcn2 were markedly increased (53-fold) in S. Typhimurium-
infected mice compared to mock-infected mice (Figure 7A).CelExpression of lipocalin-2 in the cecal mucosa was assessed at
the protein levels using western blot. While no lipocalin-2 was
detectable in the cecal mucosa of mock-infected mice, the
protein was highly abundant 48 hr after S. Typhimurium infection
(Figure 7B). The S. Typhimurium wild-type was recovered from
intestinal contents 48 hr after infection in 7-fold-higher numbers
than the iroNmutant (Figure 4B), suggesting that IroN-mediated
salmochelin uptake constituted an advantage during growth in
the inflamed cecum.
To investigate whether the presence of the iroN gene confers
an advantage only in the presence of intestinal inflammation,
we repeated the above experiments with S. Typhimurium
strains that were unable to elicit this host response. The induc-
tion of cecal inflammation in streptomycin-pretreated mice
requires the presence of functional T3SS-1 and T3SS-2 secre-
tion systems (Hapfelmeier et al., 2005). We constructed an
S. Typhimurium strain carrying mutations that prevent function-
ality of T3SS-1 (invA) and T3SS-2 (spiB). Streptomycin-pre-
treated wild-type mice (C57BL/6) were inoculated intragastri-
cally with sterile LB broth (mock infection) or with a 1:1
mixture of the S. Typhimurium invA spiB mutant and an S. Ty-
phimurium invA spiB iroN mutant. Compared to mock-infected
mice, no marked increases in cytokine transcription (Il17, Il22,
Kc, and Tnfa) were detected in the cecal mucosa of mice in-
fected with a mixture of the S. Typhimurium invA spiB mutant
and the invA spiB iroN mutant (Figure 5), and no marked inflam-
matory changes were detected microscopically (Figure 6).
Increased expression of Lcn2 transcription in the cecal mucosa
was not detected by real-time PCR, and little lipocalin-2
expression was detected by western blot (Figure 7). These
data confirmed that infection with T3SS-1/T3SS-2-deficient
S. Typhimurium strains does not trigger marked cecal inflam-
mation in streptomycin-pretreated mice. Importantly, the S. Ty-
phimurium invA spiB mutant and the invA spiB iroN mutant
were recovered in equal numbers from intestinal contents 48 hr
after infection (Figure 4B). These data suggested that in the
absence of intestinal inflammation, the IroN-mediated salmo-
chelin uptake did not provide a significant selective advantage
during growth in the intestine.l Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier Inc. 481
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Salmonella Resistance to InflammationFigure 5. Inflammatory Responses Elicited in the Cecum of Streptomycin-Pretreated Mice 48 hr after S. Typhimurium Infection Assessed by
Measuring Cytokine Transcription
(A–D) Transcript levels of Il17a (A), Il22 (B), Kc (C), and Tnfa (D) in wild-type mice (WT, gray bars) or lipocalin-2-deficient mice (Lcn2/, black bars) 48 hr after
competitive infection (wild-type versus iroN or invA spiB versus invA spiB iroN) was measured by quantitative real-time PCR. Bars represent fold changes
(geometric means) in mRNA levels compared to a group of mock-infected wild-type mice ± SEM.To investigate whether intestinal inflammation provides
a selective advantage for S. Typhimurium strains carrying the
IroN outer membrane receptor because expression of lipoca-
lin-2 is highly induced in the inflamed intestine, above experi-
ments were repeated using lipocalin-2-deficient mice. Strepto-
mycin-pretreated lipocalin-2-deficient mice were inoculated
intragastrically with sterile LB broth (mock infection) or with
a 1:1 mixture of the S. Typhimurium wild-type and the S. Typhi-
murium iroN mutant. Inoculation with a mixture of the S. Typhi-
murium wild-type and the S. Typhimurium iroN mutant resulted
in acute cecal inflammation, as indicated by markedly increased
transcript levels of Il17, Il22, Kc, and Tnfa at 48 hr after infection
and inflammatory changes in tissue (Figures 5 and 6). As ex-
pected, lipocalin-2 expression was detected neither by real-
time PCR nor by western blot in the ceca of any of the lipoca-
lin-2-deficient mice (Figure 7). Importantly, the S. Typhimurium
wild-type and the iroNmutant were recovered in similar numbers
from intestinal contents 48 hr after infection (Figure 4B). Further-
more, the ratio of wild-type to iroN mutant (competitive index)
recovered from lipocalin-2-deficient mice was significantly lower
than that determined for wild-type mice (p < 0.05). These data
suggested that iroN confers a selective advantage during growth
in the inflamed intestine, because the encoded salmochelin
receptor IroN mediates resistance to lipocalin-2.482 Cell Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier IDISCUSSION
One host strategy for controlling colonization of unwanted
microbes is to limit the availability of iron, an essential nutrient,
by sequestering this trace element both systemically by hepci-
din-mediated acute phase responses (Ganz, 2006; Nemeth
andGanz, 2006) and locally by high-affinity iron binding proteins,
including lactoferrin secreted by neutrophils at sites of inflamma-
tion (Ong et al., 2006). To overcome this iron-withholding
defense, bacteria release high-affinity iron chelators, termed
siderophores, which can remove iron from host proteins and
are subsequently taken up by specialized bacterial transport
systems (Braun et al., 1998). The siderophore produced by
mostmembers of theEnterobacteriaceae is enterochelin, a cyclic
trimer of dihydroxybenzoylserine (O’Brien and Gibson, 1970).
The host can limit the ability of bacteria to use enterochelin for
iron acquisition by secreting lipocalin-2, a protein whose produc-
tion in tissue is induced by IL-22 (Aujla et al., 2008) and IL-17
(Conti et al., 2009; Raffatellu et al., 2008) during inflammation.
Expression of LCN2 mRNA by the inflamed intestinal epithelium
occurs in the human colon during inflammatory bowel disease
(Nielsen et al., 1996), while murine Lcn2 mRNA is present in
mouse colonic epithelium during dextran sodium sulfate-
induced colitis (Playford et al., 2006). Here we show that IL-17nc.
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Salmonella Resistance to InflammationFigure 6. Histopathology of the Cecum from Mock-Infected Mice or Mice Infected with a Mixture of the Indicated S. Typhimurium Strains
(A) Histopathological appearance of the cecum from representative animals in each group. All images were taken from H&E-stained cecal sections at the same
magnification (1003). Note marked edema in the submucosa (SM) of mice infected with S. Typhimurium wild-type versus iroN mutant. M, mucosa; L, lumen.
(B) Pathology score determined by blinded examination of cecal sections under high-power magnification. Each bar represents an individual animal.and IL-22 act in concert to induce LCN2 transcription in T84
colonic epithelial cells. Furthermore, LCN2 transcription was
induced by S. Typhimurium infection in the intestinal epithelium
of rhesus macaques, resulting in secretion of lipocalin-2 into
the intestinal lumen. These data suggested that lipcalin-2 is an
antimicrobial encountered in the lumen of the inflamed intestine.
Lipocalin-2 specifically binds and inactivates enterochelin, re-
sulting in a bacteriostatic activity for some commensal bacteria,
such as Escherichia coli (Berger et al., 2006; Flo et al., 2004;
Goetz et al., 2002). The iroBCDE iroN gene cluster ofS. Typhimu-
rium encodes proteins involved in the biosynthesis and uptake of
salmochelin, a glycosylated derivative of enterochelin (Bister
et al., 2004; Hantke et al., 2003; Zhu et al., 2005). Salmochelin
is not bound by lipocalin-2, and its production therefore confers
lipocalin-2 resistance (Crouch et al., 2008; Fischbach et al.,
2006). Here we show that lipocalin-2 resistance conferred
a specific benefit during growth of S. Typhimurium in the in-
flamed cecum of mice. The streptomycin-pretreated mouse
model has limitations, because exudative intestinal inflammation
is induced artificially by antibiotic treatment. However, our
results show that lipocalin-2 production is also a prominent
host response to S. Typhimurium infection in the intestinal
mucosa of rhesus macaques, a highly relevant model for human
gastroenteritis. Our results suggest that acquisition of the
iroBCDE iroN gene cluster by S. Typhimurium may represent
a specific adaptation to life in the inflamed intestine. A potential
role of lipocalin-2 resistance in promoting colonization of the in-
flamed nasal mucosa has recently been proposed for Strepto-Celcoccus pneumoniae and Haemophilus influenzae (Nelson et al.,
2005).
The main virulence factors involved in inducing intestinal
inflammation, T3SS-1 and T3SS-2 (Hapfelmeier et al., 2005; Tso-
lis et al., 1999), were acquired by horizontal gene transfer early
after divergence of the genus Salmonella from the E. coli lineage
and are present in all members of the species S. enterica (Hensel
et al., 1997; Li et al., 1995; Ochman and Groisman, 1996). It
seems reasonable to assume that to ensure survival, acquisition
of T3SS-1 and T3SS-2 had to be accompanied by acquisition of
genes that confer resistance to antimicrobials encountered in the
inflamed intestine. Consistent with this idea, the iroBCDE iroN
gene cluster is present in all members of the species S. enterica
but is absent from the genomes of commensal E. coli strains
(Ba¨umler et al., 1997, 1998). The only E. coli isolates in which
the iroBCDE iroN gene cluster is present are uropathogenic
E. coli (UPEC) (Bauer et al., 2002; Sorsa et al., 2003). This distri-
bution is consistent with the concept that the iroBCDE iroN gene
cluster represents an adaptation to life at inflamed mucosal
surfaces, which is an environment encountered by both UPEC
(cystitis) and S. Typhimurium (gastroenteritis).
In addition to overcoming lipocalin-2-mediated iron with-
holding, S. Typhimurium likely needs to resist many other
antimicrobial defense mechanisms encountered in the inflamed
intestine. Candidate antimicrobials whose transcripts are prom-
inently induced in the intestinal mucosa during S. Typhimurium
infection include inducible nitric oxide synthase (iNOS, encoded
by NOS2), regenerating islet-derived 3 gamma (RegIIIg),l Host & Microbe 5, 476–486, May 21, 2009 ª2009 Elsevier Inc. 483
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(IDO), dual oxidase (Duox), and defensins (Godinez et al., 2009;
Raffatellu et al., 2007, 2008; Zheng et al., 2008). Here we show
that IL-22 induced expression of NOS2 and MUC4 in human
intestinal epithelial cells, suggesting a possible cellular source
for the high mRNA levels of these genes observed in the ileal
mucosa of rhesus macaques during S. Typhimurium infection
(Raffatellu et al., 2008). In mice lacking iNOS and NADPH
oxidase, S. Typhimurium is recovered in reduced numbers from
intestinal contents at 48 hr after infection, although this difference
is not statistically significant (Ackermann et al., 2008). Research
on the potential role of S. Typhimurium resistance mechanisms
against the various antimicrobials encountered in the inflamed
intestine represents an exciting area for future study.
Figure 7. Lipocalin-2 Expression in the Cecal Mucosa of Mice
(A and B) Lipocalin-2 expression detected by quantitative real-time PCR (A) or
by western blot (B) in the cecal mucosa of streptomycin-pretreated mice 48 hr
after S. Typhimurium infection. Bars represent fold changes (geometric
means) in mRNA levels compared to a group of mock-infected wild-type
mice ± SEM (A). Lipocalin-2 expression in protein extracts from the cecal
mucosa of individual mice was detected with anti-mouse lipocalin-2 antibody
(a-lipocalin-2) (B). Detection of tubulin with anti-mouse tubulin antibody
(a-tubulin) served as a loading control for each sample. PC, positive control
sample from animal #3; NC, negative control sample from animal #8.484 Cell Host & Microbe 5, 476–486, May 21, 2009 ª2009 ElsevierEXPERIMENTAL PROCEDURES
Tissue Culture Assays
T84 cells were grown in a 1:1 mixture of DMEM/F12 and 10% fetal calf serum
(GIBCO). To achieve polarization, cells were seeded on the apical compart-
ment in 12 mm diameter Transwell plate (Corning Costar; Lowell, MA) and
utilized when a transepithelial resistance of at least 1500 U.cm2 was reached.
Stimulation with Cytokines
Recombinant human IL-17, IL-22, and IFNgwere obtained fromR&D Systems;
Minneapolis, MN and utilized at the following final concentrations: IL-17,
100 ng/ml; IL-22, 100 ng/ml; IFNg, 40 ng/ml. Each stimulation experiment
was performed a minimum of four times.
Gene Expression Profiling
Gene expression profiles (GEO accession number GSE11345) in polarized T84
cells were monitored utilizing the GeneChip Human Genome U133 Plus 2.0
Array (Affymetrix; Santa Clara, CA). For each treatment group, total RNA
from four tissue culture wells was analyzed. A minimum 2-fold difference in
transcription between control and experimental samples was used as criteria
for identifying a ‘‘change’’ in gene expression (P value < 0.05; 95% confi-
dence).
Real-Time PCR
For analysis of gene expression by real-time PCR, total RNA was extracted
with TRI Reagent (Molecular Research Center; Cincinnati, OH) and processed
as described earlier (Raffatellu et al., 2007). Real-time PCR was performed
using SYBR Green (Applied Biosystems; Foster City, CA) and the 7900HT
Fast Real-Time PCR System. The data were analyzed using the comparative
D-Ct method (Applied Biosystems). Analysis of the copy number of rhesus
LCN2 was performed by comparing crossing points of experimental cDNA
to standard curves generated from a plasmid that contained a fragment of rhe-
sus LCN2 cDNA (Hornsby et al., 2008). A list of the real-time primers used in
this study is provided in Table S1.
Bacterial Strains and Culture Conditions
IR715 is a fully virulent, nalidixic acid-resistant derivative of S. Typhimurium
wild-type isolate ATCC 14028. Construction of IR715 derivatives carrying
mutations in iroBC, iroN, invA, or spiB is described in the Supplemental Exper-
imental Procedures. A complete list of strains, plasmids, and primers used for
cloning and strain construction is provided in Tables S2 and S3. All strains
were grown aerobically at 37C in LB broth unless otherwise noted.
Bacterial Growth in Cell Culture Supernatant
S. Typhimurium wild-type and iroBC mutant were grown overnight in iron-
limiting conditions (Nutrient Broth supplemented with 0.2 mM 2,20-dipyridyl)
at 37C with aeration overnight. Approximately 1000 cfu were inoculated
into tissue culture medium (DMEM/F12), DMEM/F12 containing human lipoca-
lin-2 (100 ng/ml) (R&D Systems), DMEM/F12 containing human lipocalin-2
(100 ng/ml) and ferrioxamine B (1 mg/ml), or the media collected from the baso-
lateral side of Transwell plate 24 hr after stimulation with IL-17 and IL-22 or
mock control. cfu were enumerated by plating serial dilution 5 hr after inocula-
tion. The experiment was performed three times.
Immunoblot
Total protein was extracted from mouse cecum using TRI Reagent (Molecular
Research Center). Total protein (15 mg) was resolved by SDS-PAGE and trans-
ferred to a PVDF membrane. Detection of mouse tubulin was performed with
a primary rabbit polyclonal antibody (Cell Signaling Technology; Danvers, MA),
and detection of mouse lipocalin-2 was performed with a primary rabbit poly-
clonal antibody (R&DSystems). As secondary antibody, a secondary goat anti-
rabbit conjugate to horseradish peroxidase (HRP) (Jackson Laboratory) was
used.
Enzyme-Linked ImmunoSorbent Assay
Supernatant from both the apical and the basolateral compartments of polar-
ized T84 cells was collected 24 hr poststimulation. Secretion of CCL20 and lip-
ocalin-2 was detected by using commercially available kits (R&D Systems).Inc.
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Localization of rhesus mRNA transcripts in formalin-fixed, paraffin-embedded
ileal sections was performed as described earlier (Santos et al., 2002). Probes
for target genes were amplified from rhesus cDNA using the primers reported
in Table S1 and cloned into PCR2.1 (Invitrogen). Each probe (LCN2 and
plasmid control) was biotin labeled using the NEBlot Phototype Kit according
to instructions from the manufacturer (New England Biolabs; Ipswich, MA).
Detection of Lipocalin-2 in Tissue of Rhesus Macaques
Generation of an anti-rhesus lipocalin-2 rabbit polyclonal antibody is described
under Supplemental Experimental Procedures. Immunohistochemical staining
of lipocalin-2 was performed on formalin-fixed, paraffin-embedded ileal
sections using a rabbit polyclonal antibody derived from recombinant rhesus
lipocalin-2, followed by detection with a secondary anti-rabbit IgG antibody
(Vector Laboratories; Burlingame,CA). Staining of an adjacent sectionwith pre-
immune rabbit serumwas used as a control. Detection of lipocalin-2 in the fluid
collected from ligated ileal loops of rhesus macaques is described under
Supplemental Experimental Procedures.
Mouse Experiments
We used both C57BL/6 wild-type and lipocalin-2-deficient (Lcn2/) mice.
Generation of Lcn2/ mice (Berger et al., 2006) is described in the Supple-
mental Experimental Procedures. Groups of six mice were pretreated with
streptomycin (0.1 ml of a 200 mg/ml solution in sterile water) intragastrically
prior to mock-infection or inoculation with a mixture of S. Typhimurium strains
(53 108 cfu/animal). At 48 hr after infection, mice were euthanized and cecum
was collected for isolation of mRNA and protein and for histopathological anal-
ysis. Colon contents were collected, and serial 10-fold dilutions were plated for
enumerating bacterial cfu on agar plates containing the appropriate anti-
biotics. Data were normalized by dividing the output ratio (cfu of the wild-
type/cfu of themutant) by the input ratio (cfu of thewild-type/cfu of themutant).
Statistical Analysis
Microarray data were analyzed using model-based algorithms (Affymetrix
GeneChip Operating System software, dChip, http://biosun1.harvard.edu/
complab/dchip) and t tests. Differences between treatment groups in fold
changes in mRNA levels measured by real-time PCR, protein levels measured
by ELISA, NO production measured by Griess assays, and bacterial numbers
were analyzed by ANOVA followed by Student’s t test. A P value equal or
below 0.05 was considered statistically significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, three tables, and two figures and can be found online at
http://www.cell.com/cell-host-microbe/supplemental/S1931-3128(09)00108-5.
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